SelectScience
Join Free
Accelerating Science
NewsClinical Diagnostics

Genetic Analysis AS awarded NOK 16 million (USD 1.9 million) to develop new microbiome marker to aid treatment of inflammatory bowel disease

Genetic Analysis AS

It is hoped the project will lead to improved quality of life for patients

16 Jun 2021
Ellen Simms
Product and Reviews Editor

Industry news

Molecular diagnostics specialist, Genetic Analysis AS (GA), has announced that the Norwegian Research Council has approved its grant application of NOK 16 million (USD 1.9 million) for its project developing new innovative microbiome-based diagnostics to be used to aid selection and treatment of inflammatory bowel disease (IBD) patients.

In this project, GA will develop an easy to use, in vitro diagnostic test that profiles gut microbiota to predict disease progression and treatment regimes in patients with ulcerative colitis. The development and validation of the test will be done in close collaboration with R&D partners at Akershus University Hospital (Prof Stefan Brackman), Norway and Sahlgrenska University (Prof Lena Öhman) Hospital/University of Gothenburg, Sweden.

“We are pleased to receive this grant from the Norwegian Research Council in supporting GA’s work to improve the treatment regime for IBD patients. This will not only improve treatment outcome and quality of life for patients suffering this debilitating disease but also contribute to lowering the huge costs related to treatment,” commented Ronny Hermansen, CEO of Genetic Analysis.

“Improved treatment regimens for IBD patients represent a major unmet medical need, and patients will benefit strongly from new innovative markers that can aide diagnoses and selection of treatment for these life-long diseases. We look forward to supporting GA in their development of new innovative diagnostics for IBD patients” said leading IBD authority Prof. Lena Öhman.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Genetic Analysis ASCompany website

Tags

Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Irritable Bowel SyndromeMicrobiomeMicrobiome research focuses on the complex communities of microorganisms living in and on humans, animals, plants, and environments. It plays a crucial role in health, disease, and ecological balance. Explore tools and resources for microbiome analysis, including sequencing platforms and bioinformatics software.Inflammatory Diseases

Related articles

Genetic Analysis AS awarded NOK 16 million (USD 1.9 million) to develop new microbiome marker to aid treatment of inflammatory bowel disease